Modeling is an important and widely used method for demonstrating the value of medical interventions. Models combine the best available clinical, economic, and quality of life data to answer “what-if” questions related to the clinical and economic impact of a product. They are often used to inform decision making during clinical development, as part of a reimbursment submission, or to extrapolate trial-based findings to new populations, countries, endpoints, comparators or time horizons.

i3 Innovus has an outstanding track record in the development of models to support pricing, reimbursement, and market access. Such models can be developed with the flexibility to accommodate epidemiology and health care data from virtually any country, such that one model serves multiple regions. As well, even complex models can be created with user-friendly interfaces for use in medical marketing, physician medical education, or sales force activities.

i3 Innovus experience includes:

• Decision analytic models
• Markov models
• Monte Carlo simulation models
• Global models and country-specific applications
• User-friendly interfaces for marketing activities
• “Go/No-Go” models to inform drug development decision making
• A wide range of therapeutic areas including: cardiology, respirology, infectious disease, oncology, rheumatology, and CNS
• Budget impact models Canadian Guidelines for Budget Impact Analysis